Definitive Healthcare (NASDAQ:DH) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Definitive Healthcare (NASDAQ:DH) from a hold rating to a buy rating in a research report released on Saturday.

Other research analysts also recently issued reports about the stock. Canaccord Genuity Group lowered their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating on the stock in a research report on Friday, February 27th. Stephens decreased their target price on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a research note on Friday, February 27th. Zacks Research lowered Definitive Healthcare from a “hold” rating to a “strong sell” rating in a report on Thursday, March 5th. Barclays dropped their price target on Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating on the stock in a research report on Monday, December 8th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Definitive Healthcare in a research note on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $3.52.

Definitive Healthcare Price Performance

DH stock opened at $1.13 on Friday. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $159.74 million, a P/E ratio of -0.90 and a beta of 1.66. The business has a 50 day simple moving average of $1.89 and a 200-day simple moving average of $2.68. Definitive Healthcare has a twelve month low of $1.07 and a twelve month high of $4.70.

Institutional Trading of Definitive Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in the company. New York State Common Retirement Fund raised its holdings in Definitive Healthcare by 0.4% during the second quarter. New York State Common Retirement Fund now owns 766,433 shares of the company’s stock worth $2,989,000 after purchasing an additional 3,066 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in Definitive Healthcare by 32.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 17,811 shares of the company’s stock valued at $72,000 after purchasing an additional 4,407 shares in the last quarter. State of Alaska Department of Revenue boosted its holdings in Definitive Healthcare by 109.3% in the 4th quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock valued at $32,000 after purchasing an additional 5,970 shares in the last quarter. Invesco Ltd. increased its position in Definitive Healthcare by 5.8% during the 4th quarter. Invesco Ltd. now owns 117,427 shares of the company’s stock worth $337,000 after purchasing an additional 6,400 shares during the period. Finally, Raymond James Financial Inc. acquired a new position in Definitive Healthcare during the 2nd quarter worth approximately $32,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.